DermTech Seeks to Tackle Melanoma Testing with Genomic Technology | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – Looking to tap into what its chief executive said may be the biggest market for genetic testing in the world, DermTech International is progressing in developing a test that it claims is more accurate than any melanoma detection test currently available.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.